[Pr-01]What I learned through the research for ataxic disorders
○Hidenao Sasaki(Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)
59th Annual Meeting of the Japanese Society of Neurology
May 23 - May 26, 2018Royton Sapporo/Nitori Culture Hall and Hotel Sapporo Geibunkan/Sapporo Education and Culture Hall
You can search for presentations in this event.
Search
59th Annual Meeting of the Japanese Society of Neurology
May 23 - May 26, 2018Royton Sapporo/Nitori Culture Hall and Hotel Sapporo Geibunkan/Sapporo Education and Culture Hall
You can search for presentations in this event.
SearchSearch Results(2,032)
[PL-01]Meeting the Dementia Challenge in the UK
○Martin Rossor1,2(1.UCL, Institute of Neurology, UK, 2.NIHR, UK)
[SPL-01]Multiple system atrophy
○Gregor K. Wenning, Florian Krismer(Medical University Innsbruck, Department of Neurology, Austria)
[SL-01]A Physician's Development of Therapeutics for HIV Infection and AIDS
○Hiroaki Mitsuya(National Center for Global Health and Medicine Research Institute)
[SL-02]116 Years of "old and new" Japanese Society of Neurology (1902-2018): Lessons from the history
○Shigeki Kuzuhara(Division of Basic Nursing, School of Nursing, Suzuka University of Medical Science)
[AW-01-1]Genetic analysis in nemaline myopathy
○Satoko Miyatake(Clinical Genetics Department, Yokohama City University Hospital)
[AW-01-2]Twenty years' activities of the Fukuoka Intractable Neurological Disease Medical Care Network
○Jun-ichi Kira(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University)
[AW-01-3]Anti-glycolipid antibody assay for neurological diseases
○Susumu Kusunoki(Department of Neurology, Kindai University Faculty of Medicine)
[AW-01-4]To elucidate the pathogenesis of Parkinson's disease
○Nobutaka Hattori(Department of Neurology, Juntendo University)
[AW-02-1]Molecular genetic studies in Parkinson's disease
○Manabu Funayama(Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University)
[AW-02-2]Neuropathology of alpha-synucleinopathy
○Koichi Wakabayashi(Department of Neuropathology, Hirosaki University Graduate School of Medicine)
[EANF-01]Introduction
○Hidehiro Mizusawa(National Center of Neurology and Psychiatry, Japan)
[EANF-01-1]Flaviviral infection and the CNS
○Eng Eong Ooi1, Jenny G. Low1,2, Shirin Kalimuddin2, Kevin Tan1,3, Yvonne FZ Chan2, Sze Chien Ang2, Limin Wijaya2(1.Duke NUS Medical School, Programme in Emerging Infectious Diseases, Singapore, 2.Singapore General Hospital, Department of Infecious Diseases, Singapore, 3.National Neuroscience Institute, Tan Tock Seng Hospital, Singapore)
[EANF-01-2]Tick-borne encephalitis as a matter of public health
○Kentaro Yoshii(Laboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University, Japan)
[EANF-01-3]TBE Clinical Features: clinico-pathological features of a Japanese case from central Hokkaido Island
○Yasutaka Tajima1, Hiroaki Yaguchi1, Yasunori Mito1, Sari Iwasaki2, Yuichiro Fukasawa2(1.Department of Neurology, Sapporo City General Hospital, Japan, 2.Department of Pathology, Sapporo City General Hospital, Japan)
[EANF-01-4]Dissecting the neurovirulence and viscerotropism determinants of Japanese Encephalitis virus
○Cheng-Feng Qin1,2(1.Department of Virology, Beijing Institute of Microbiology and Epidemiology, China, 2.State Key Laboratory of Pathogen and Biosecurity, Beijing 100071, China)
[EANF-01-5]Recent advances in Neurological manifestations of Dengue infection
○Rajesh Verma(Professor in Department Of Neurology, King George Medical University, India)
[EANF-02-1]New approaches to prevent diseases caused by West Nile virus and other mosquito-borne flaviviruses
○Roy A. Hall(Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia)
[EANF-02-2]Examination of neuronal injury by West Nile virus infection
○Hirofumi Sawa1,2, Shintaro Kobayashi1,3, Hiroki Yamaguchi1,4, Wallaya Phongphaew1, Michihito Sasaki1, Yasuko Orba1(1.Research Center for Zoonosis Control, Hokkaido University, Japan, 2.Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Japan, 3.Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Japan, 4.Hokkaido Institute of Public Health, Japan)
[EANF-02-3]Pathological and epidemiological investigation for congenital Zika virus infection
○Tadaki Suzuki, Minoru Tobiume, Hideki Hasegawa(Department of Pathology, National Institute of Infectious Diseases, Japan)
[EANF-02-4]Emerging infectious diseases (EIDs) preparedness and response: an example of Zika virus
○Satoko Otsu(WHO Viet Nam Country Office, Vietnam)
[NSF-01-1]Molecular and cellular mechanisms of mitochondrial quality control in Parkinson's disease
○Wolfdieter Springer1,2(1.Department of Neuroscience, Mayo Clinic Jacksonville, USA, 2.Mayo Clinic College of Medicine and Science, Graduate School of Biomedical Sciences, USA)
[NSF-01-2]Collapse of mitochondria-associated membrane (MAM) as common pathomechanism for motor neuron disease
○Koji Yamanaka(Research Institute of Environmental Medicine, Nagoya University, Japan)
[NSF-01-3]Endosomal-lysosomal pathway in Alzheimer's disease
○Gunnar K. Gouras(Experimental Dementia Research Unit, Lund University, Sweden)
[NSF-01-4]Rab small GTPases in neuronal networks: dysregulation of Rabs in neurodegeneration
○Mitsunori Fukuda(Graduate School of Life Sciences, Tohoku University, Japan)
[OC-01-1]Signs and symptoms of early stage ALS: especially, differential diagnosis from cervical spondylosis
○Tetsuo Ando(Department of Neurology, Anjo Kosei Hospital)
[OC-01-2]Practice and usefulness of muscule ultrasound in diagnosis of ALS in early stage
○Hiroki Yamazaki, Hiroyuki Nodera, Naoko Takamatsu, Yuishin Izumi, Ryuji Kaji(Department of Neurology, Tokushima University Hospital)
[OC-01-3]Early diagnosis of ALS: the role of electrodiagnosic tests
○Masahiro Sonoo(Department of Neurology, Teikyo University School of Medicine)
[OC-01-4]In-vivo imaging of the pathogenetic cascade in ALS
○Makoto Higuchi(National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology)
[OC-01-5]The utility of the examination of the cerebrospinal fluid
○Masato Hosokawa(Dementia Research Project, Tokyo Metropolitan Instutute of Medical Science)
[OC-01-6]Basic and clinical analysis of symptom spread in ALS
○Takanori Yokota(Department of Neurology and Neurological Science,Tokyo Medical and Dental University)
[OC-02-1]SCA31: molecular pathogenesis and role of RNA chaperone
○Kinya Ishikawa1,2, Taro Ishiguro2, Yoshitaka Nagai3(1.The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, Japan, 2.Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Japan, 3.Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan)
[OC-02-2]Repeat associated Non-AUG initiated (RAN) translation in Fragile X-associated Tremor Ataxia Syndrome
○Peter K. Todd(University of Michigan, USA)
[OC-02-3]SCA42: new calcium channelopathy
○Hideshi Kawakami, Hiroyuki Morino, Yukiko Matsuda(Department of Epidemiology Research Institute for Radiology & Medicine Hiroshima University, Japan)
[OC-02-4]Molecular Pathology of Spinocerebellar Ataxia 10
○Tetsuo Ashizawa1, Karen N. McFarland2(1.Houston Methodist Research Institute, USA, 2.University of Florida, USA)
[HT-02-1]Engineering selectivity into therapeutic oligonucleotides through chemical design
○Punit P. Seth(Ionis Pharmaceuticals, Inc., Canada)
[HT-02-2]Antisense therapy for Fukuyama congenital muscular dystrophy
○Tatsushi Toda(Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan)
[HT-02-3]Recent progress of DNA/RNA heteroduplex oligonucleotide
○Tetsuya Nagata(Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)
[HT-02-4]A first Antisense Oligonucleotide (ASO) therapy, Nusinersen, for Spinal Muscular Atrophy
○Shinichi Torii(Biogen Japan Ltd., Japan)
[G-01-1]Epilepsy and the driver's license
○Kazutaka Jin(Department of Epileptology, Tohoku University Graduate School of Medicine)
[G-01-2]Antiepileptic treatment in women of childbearing age
○Masako Kinoshita(Department of Neurology, Utano National Hospital)
[G-01-3]New guideline on the management of status epilepticus
○Masahiro Mizobuchi(Epilepsy Center, Department of Neurology, Nakamura Memorial Hospital)
[G-01-4]Selection of anti-epileptic medicine
○Naoki Akamatsu1,2(1.Department of Neurology, International University of Health and Welfare, 2.Neuroscience Center, Fukuoka Sanno Hospital)
[S-01-1]Classification of myositis
○Ichizo Nishino(Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
[S-01-2]Anti-ARS myopathy
○Shigeaki Suzuki(Department of Neurology, Keio University School of Medicine)
[S-01-3]Cancer associated myositis
○Jun Shimizu(Department of Neurology, The University of Tokyo Hospital)
[S-01-4]The cutting edge of sporadic inclusion body myositis
○Satoshi Yamashita(Department of Neurology, Graduate School of Medical Sciences, Kumamoto University)
[S-01-5]Dermatomyositis
○Yoshinao Muro(Division of Connective Tissue Disease & Autoimmunity, Department of Dermatology, Nagoya University Graduate School of Medicine)
[S-02-1]Japan Spastic Paraplegia Research Consortium: what is known about hereditary spastic paraplegia
○Kishin Koh1, Hiroyuki Ishiura2, Yuta Ichinose1, Masaki Tanaka3, Jun Mitsui2,3, JASPAC4, Shoji Tsuji3,5, Yoshihisa Takiyama1(1.Department of Neurology, University of Yamanashi, 2.Department of Neurology, The University of Tokyo, 3.Department of Molecular Neurology, The University of Tokyo, 4.Japan spastic paraplegia research consortium, 5.International University of Health and Welfare Graduate School)
[S-02-2]Intrathecal baclofen therapy for hereditary spastic paraplegia
○Yuta Ichinose1, Kishin Koh1, Hiroyuki Ishiura2, Tatsushi Toda2, Shoji Tsuji3, Yoshihisa Takiyama1, JASPAC4(1.Department of Neurology, Graduate School of Medical Sciences, University of Yamanashi, 2.Department of Neurology, Graduate School of Medicine, University of Tokyo, 3.Department of Molecular Neurology, Graduate School of Medicine, University of Tokyo, 4.Japan Spastic Paraplegia Research Consortium)
2,032 results ( 1 - 50 )
- 1
- ...